EcoDrugPlus

Ribosomal Protein L14

Ensembl ID : ENSMMNG00015018899
Gene Symbol: RPL14
2 Cross references
251 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSMMNG00015001857
Gene Symbol: RPL18
3 Cross references
318 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSMMNG00015018510
Gene Symbol: RPL19
3 Cross references
242 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSMMNG00015014841
Gene Symbol: RPL22
3 Cross references
89 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSMMNG00015020663
Gene Symbol: RPL26
3 Cross references
137 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSMMNG00015002911
Gene Symbol: RPL28
3 Cross references
194 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSMMNG00015012118
Gene Symbol: RPL32
3 Cross references
86 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSMMNG00015019387
Gene Symbol: RPL35
3 Cross references
247 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSMMNG00015004368
Gene Symbol: RPL36
3 Cross references
210 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSMMNG00015003911
Gene Symbol: RPL37
3 Cross references
100 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSMMNG00015006797
Gene Symbol: RPL37A
3 Cross references
34 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSMMNG00015015175
Gene Symbol: RPL38
3 Cross references
194 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).